| Particulars |
|
|
|
| Company Name
| Glaxosmithkline Pharmaceuticals Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
110.40 |
| Sales(₹ Cr.) |
3,790.20 |
NP (₹ Cr.) |
951.37 |
| NP Var% |
10.00 |
Div% |
570.00 |
| CPS(₹) |
60.10 |
EPS (₹) |
56.20 |
| Traded Value(₹ Lakhs) |
60.19 |
52 Week High |
3,121.00 |
| 52 Week Low |
2,088.00 |
Price BSE |
2,539.00 |
| Price NSE |
2,540.00 |
Market Capital (₹ Cr.) |
43,011.35 |
| P/C Ratio |
42.30 |
P/E Ratio |
45.20 |
| Price Vs.BV |
23.00 |
|
| Latest Quarter |
| Year End |
202609 |
Sales (₹ Cr.) |
1,179.91 |
| NP(₹ Cr.) |
334.62 |
NP Var % |
32.00 |
| Trailing Twelve Months |
| Year End |
202609 |
Sales |
3,526.90 |
| OPM |
24.32 |
NP |
795.84 |
| NP Var% |
20.45 |
EPS |
67.30 |
| PE |
37.73 |
|
|